Menachem Banai

Summary

Country: Israel

Publications

  1. ncbi Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene
    Svetlana Bardenstein
    Department of Bacteriology, Kimron Veterinary Institute, Bet Dagan 50250, Israel
    J Clin Microbiol 40:1475-80. 2002
  2. ncbi The myth of Brucella L-forms and possible involvement of Brucella penicillin binding proteins (PBPs) in pathogenicity
    M Banai
    Department of Bacteriology, Kimron Veterinary Institute, PO Box 12, Bet Dagan 50250, Israel
    Vet Microbiol 90:263-79. 2002
  3. ncbi Control of small ruminant brucellosis by use of Brucella melitensis Rev.1 vaccine: laboratory aspects and field observations
    Menachem Banai
    Department of Bacteriology, Kimron Veterinary Institute, PO Box 12, Bet Dagan 50250, Israel
    Vet Microbiol 90:497-519. 2002
  4. ncbi Attenuated bioluminescent Brucella melitensis mutants GR019 (virB4), GR024 (galE), and GR026 (BMEI1090-BMEI1091) confer protection in mice
    Gireesh Rajashekara
    Department of Animal Health and Biomedical Sciences, University of Wisconsin-Madison, 1656 Linden Drive, Madison, WI 53706, USA
    Infect Immun 74:2925-36. 2006
  5. ncbi The use of ELISA in a seroprevalence study of Brucella antibodies in West Bank Palestinian women of childbearing age
    Rebekah Karplus
    Int J Infect Dis 11:367-8. 2007

Collaborators

Detail Information

Publications5

  1. ncbi Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene
    Svetlana Bardenstein
    Department of Bacteriology, Kimron Veterinary Institute, Bet Dagan 50250, Israel
    J Clin Microbiol 40:1475-80. 2002
    ..This method facilitates identification of the Rev.1 vaccine strain in both animals and humans in Israel...
  2. ncbi The myth of Brucella L-forms and possible involvement of Brucella penicillin binding proteins (PBPs) in pathogenicity
    M Banai
    Department of Bacteriology, Kimron Veterinary Institute, PO Box 12, Bet Dagan 50250, Israel
    Vet Microbiol 90:263-79. 2002
    ..This property is associated with high avidity to beta-lactam antibiotics. PBP2 complements the activity of PBP1. New beta-lactam antibiotics and improved vaccines might be developed based on this property...
  3. ncbi Control of small ruminant brucellosis by use of Brucella melitensis Rev.1 vaccine: laboratory aspects and field observations
    Menachem Banai
    Department of Bacteriology, Kimron Veterinary Institute, PO Box 12, Bet Dagan 50250, Israel
    Vet Microbiol 90:497-519. 2002
    ..1 vaccine strain. Despite the rapid development of new approaches in the field of vaccination, it is anticipated that in the near future the Rev.1 vaccine would remain the only accepted vaccine in national control programs...
  4. ncbi Attenuated bioluminescent Brucella melitensis mutants GR019 (virB4), GR024 (galE), and GR026 (BMEI1090-BMEI1091) confer protection in mice
    Gireesh Rajashekara
    Department of Animal Health and Biomedical Sciences, University of Wisconsin-Madison, 1656 Linden Drive, Madison, WI 53706, USA
    Infect Immun 74:2925-36. 2006
    ....
  5. ncbi The use of ELISA in a seroprevalence study of Brucella antibodies in West Bank Palestinian women of childbearing age
    Rebekah Karplus
    Int J Infect Dis 11:367-8. 2007